Research Article

Are Thyroid Autoimmune Diseases Associated with Cardiometabolic Risks in a Population with Normal Thyroid-Stimulating Hormone?

Table 3

Characteristic of subjects in terms of TPOAb, TgAb, and US.

TPO and TgAb (−)TPO/TgAb (+) and US (+) value

Men
(%)3426 (89.9)134 (3.5)
Age (year)53.80 ± 13.0454.52 ± 13.090.527
Smokers (%)55.649.60.177
Systolic BP (mmHg)134.36 ± 20.81135.56 ± 20.680.516
BMI (kg/m2)24.83 ± 3.3525.75 ± 3.450.002
WC (cm)84.26 ± 9.6086.21 ± 9.290.022
FPG (mmol/L)5.72 ± 1.565.22 ± 1.180.185
HOMA-IR1.49 ± 2.321.43 ± 0.980.038
HbA1c (%)5.62 ± 1.025.61 ± 0.890.721
LDL (mmol/L)3.07 ± 0.763.14 ± 0.680.351
HDL (mmol/L)1.36 ± 0.321.34 ± 0.310.543
TG (mmol/L)1.91 ± 1.991.84 ± 1.220.187
TC (mmol/L)5.16 ± 1.135.22 ± 1.180.536
TSH (mIU/L)2.11 ± 0.912.56 ± 1.02<0.001
T3 (nmol/L)1.77 ± 0.421.73 ± 0.360.127
T4 (nmol/L)113.59 ± 22.30110.13 ± 19.240.077
Hyperlipidemia (%)42.749.30.130
Diabetes (%)15.017.90.363
Hypertension (%)51.650.80.852
Metabolic syndrome (%)20.524.60.257
Cardiovascular events (%)7.29.00.429
Women
(%)3970 (79.4)517 (10.3)
Age (year)52.45 ± 13.1654.56 ± 12.31<0.001
Smokers (%)2.91.40.053
Systolic BP (mmHg)129.93 ± 22.07132.72 ± 23.650.008
BMI (kg/m2)24.16 ± 3.5625.11 ± 3.730.002
WC (cm)77.53 ± 10.0080.32 ± 10.05<0.001
FPG (mmol/L)5.55 ± 1.305.67 ± 1.530.061
HOMA-IR1.53 ± 1.771.78 ± 2.86<0.001
HbA1c (%)5.43 ± 0.875.59 ± 0.99<0.001
LDL (mmol/L)3.05 ± 0.793.11 ± 0.810.084
HDL (mmol/L)1.48 ± 0.321.46 ± 0.310.088
TG (mmol/L)1.46 ± 1.041.71 ± 1.88<0.001
TC (mmol/L)5.14 ± 1.165.20 ± 1.030.280
TSH (mIU/L)2.43 ± 0.992.68 ± 1.05<0.001
T3 (nmol/L)1.72 ± 0.361.75 ± 0.530.644
T4 (nmol/L)115.10 ± 19.16115.31 ± 21.450.833
Hyperlipidemia (%)30.438.9<0.001
Diabetes (%)11.515.70.006
Hypertension (%)40.646.40.013
Metabolic syndrome (%)25.535.8<0.001
Cardiovascular events (%)7.410.10.033

Data are presented as the mean ± standard deviation for continuous variables or as a percentage (%) for categorical variables. BP, blood pressure; BMI, body mass index; WC, waist circumference; FPG, fasting blood glucose; HOMA-IR, homeostasis model assessment of insulin resistance; HbA1c, glycated hemoglobin; LDL, low-density lipoprotein; HDL, high-density lipoprotein; TG, triglycerides; TC, total cholesterol; TSH, thyroid-stimulating hormone; T3, triiodothyronine; T4, thyroxin.